EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent trends and innovative strategies in the curative approach for β-thalassemia: a current prospect and future perspective

Faiza Usmani, Sheikh Umair Ali, Faiza Ahad, Saifullah

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-12908-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Faiza Usmani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, University of Karachi, Karachi, Sindh, 75270, Pakistan. Hauptthemen laut MEDLINE: beta-Thalassemia, Genetic Therapy, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β-Thalassemia, a major genetic disease affecting the global population, has seen new strategies being pursued in terms of curative attempts directed at the specific gene defect present. Iron chelation therapy and lifelong blood transfusions have historically been used to treat β-thalassemia, a severe hereditary hemoglobin condition marked by decreased or missing β-globin chain synthesis. These methods have significantly increased patient survival, but they do not offer a permanent solution and are linked to serious side effects and a high cost of care. With a focus on hematopoietic stem cell transplantation (HSCT), lentiviral gene-addition treatment, and future genome-editing techniques, this study outlines new and creative methods to long-term disease correction in β-thalassemia. Although allogeneic HSCT is still a proven treatment option, its use is constrained by the availability of donors, graft-related issues, and transplant-related hazards. Autologous hematopoietic stem cell-based gene therapy has become a significant substitute, provided the possibility of long-term transfusion independence while prevented graft-versus-host disease. With the creation of exagamglogene autotemcel (exa-cel; Casgevy), which reactivates fetal hemoglobin expression through modification of the BCL11A erythroid enhancer and has shown significant rates of sustained transfusion independence in eligible patients with transfusion-dependent β-thalassemia, CRISPR/Cas9-based genome editing has recently marked a significant clinical milestone. Notwithstanding these encouraging developments, myeloablative conditioning, long-term safety and durability, high treatment costs, complicated manufacturing requirements, and restricted accessibility continue to be major obstacles, especially in low- and middle-income nations. All things considered, the therapeutic landscape for β-thalassemia is changing from lifelong supportive management to potentially curative and transformative interventions; however, the wider application of these cutting-edge therapies depends on ongoing long-term evaluation and efforts to increase affordability and global accessibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaGenetic TherapyHematopoietic Stem Cell TransplantationHumansGene EditingBlood TransfusionCRISPR-Cas SystemsGene Therapy Agentsbeta-GlobinsLentivirus

Stichwörter der Autor:innen

CRISPR/Cas9Exagamglogene autotemcelHSCTβ-Thalassemia

Substanzen

beta-Globins

Autor:innen und Institutionen

  • Department of Biotechnology, University of Karachi, Karachi, Sindh, 75270, Pakistan.
  • Department of Biotechnology, University of Karachi, Karachi, Sindh, 75270, Pakistan. Saifullah@uok.edu.pk.

Zitieren

APA

Usmani, F., Ali, S. U., Ahad, F., & Saifullah (2026). Recent trends and innovative strategies in the curative approach for β-thalassemia: a current prospect and future perspective. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12908-2

Vancouver

Usmani F, Ali SU, Ahad F, Saifullah. Recent trends and innovative strategies in the curative approach for β-thalassemia: a current prospect and future perspective. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-12908-2

BibTeX
@article{Usmani2026,
  author = {Usmani, Faiza and Ali, Sheikh Umair and Ahad, Faiza and Saifullah},
  title = {Recent trends and innovative strategies in the curative approach for β-thalassemia: a current prospect and future perspective},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-12908-2}
}
Kostenlos starten →